REQUEST A DEMO
Total
USD $0.00
Search more companies

Sanofi-aventis Slovakia s.r.o. (Slovakia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sanofi-aventis Slovakia s.r.o. Profile Updated: March 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sanofi-aventis is one of the pharmaceutical companies in the world. The company provides patients and health professionals in the Slovak Republic effective therapeutic solutions for disease in 7 major therapeutic areas: central nervous system, internal medicine, metabolism, cardiovascular system, oncology, thrombosis and vaccines. Sanofi-aventis is visible in Slovakia through its medical representatives who promote its products.

Headquarters
Einsteinova 24
Bratislava; Bratislavsky; Postal Code: 85101

Contact Details: Purchase the Sanofi-aventis Slovakia s.r.o. report to view the information.

Website: http://www.sanofi.sk

Basic Information
Total Employees:
Purchase the Sanofi-aventis Slovakia s.r.o. report to view the information.
Outstanding Shares:
Purchase the Sanofi-aventis Slovakia s.r.o. report to view the information.
Registered Capital:
Purchase the Sanofi-aventis Slovakia s.r.o. report to view the information.
Financial Auditors:
Purchase the Sanofi-aventis Slovakia s.r.o. report to view the information.
Incorporation Date:
January 05, 1993
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Attorney
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Sanofi-aventis Slovakia s.r.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
-99.71%
Total operating revenue
-99.71%
Operating profit (EBIT)
-77.14%
Net Profit (Loss) for the Period
-99.85%
Total assets
-46.71%
Total equity
-10.89%
Operating Profit Margin (ROS)
127.19%
Net Profit Margin
-6.94%
Return on Equity (ROE)
-39.55%
Quick Ratio
33.87%
Cash Ratio
0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?